SECOND AMENDMENT TO INTELLECTUAL PROPERTY SECURITY AGREEMENT (APDN B.V.I. INC.)Intellectual Property Security Agreement • August 13th, 2019 • Applied Dna Sciences Inc • Services-miscellaneous business services • New York
This SECOND AMENDMENT TO INTELLECTUAL PROPERTY SECURITY AGREEMENT (this “Amendment”), dated as of July 19, 2019, is made by APDN (B.V.I.) INC., a corporation organized under the laws of the British Virgin Islands (the “Grantor”) in favor of DELAWARE TRUST COMPANY, a Delaware corporation, as collateral agent (together with its successors and assigns, in such capacity, the “Collateral Agent”) for the benefit of the Secured Parties (as defined in the Guaranty and Security Agreement referred to below).
SECOND AMENDMENT TO INTELLECTUAL PROPERTY SECURITY AGREEMENT (APPLIED DNA SCIENCES, INC.)Intellectual Property Security Agreement • August 13th, 2019 • Applied Dna Sciences Inc • Services-miscellaneous business services • New York
This SECOND AMENDMENT TO INTELLECTUAL PROPERTY SECURITY AGREEMENT (this “Amendment”), dated as of July 19, 2019, is made by APPLIED DNA SCIENCES, INC., a Delaware corporation (the “Grantor”) in favor of DELAWARE TRUST COMPANY, a Delaware corporation, as collateral agent (together with its successors and assigns, in such capacity, the “Collateral Agent”) for the benefit of the Secured Parties (as defined in the Security Agreement referred to below).
SECOND OMNIBUS AMENDMENT AGREEMENTOmnibus Amendment Agreement • August 13th, 2019 • Applied Dna Sciences Inc • Services-miscellaneous business services • New York
This SECOND OMNIBUS AMENDMENT AGREEMENT (this “Amendment”), dated as of July 19, 2019 (the “Effective Date”), is entered into by and among APPLIED DNA SCIENCES, INC., a Delaware corporation (the “Issuer”), APDN (B.V.I.) INC., a corporation organized under the laws of the British Virgin Islands (the “Guarantor”, and together with the Issuer, collectively, the “Grantors” and each a “Grantor”), DELAWARE TRUST COMPANY, a Delaware corporation, as collateral agent (together with its successors and assigns, in such capacity, the “Collateral Agent”) for the benefit of the Buyers (defined below) and each of the investors listed on Schedule I attached hereto (each, a “Buyer” and collectively, the “Buyers”; the Buyers and the Collateral Agent are collectively, together with their successors and assigns, collectively, the “Secured Parties”).
